FDA approves new drug to treat common form of muscular dystrophy based on research from U of A scientist
Created using synthetic DNA, viltolarsen is an excellent example of precision medicine. The U.S. FDA has approved a drug called viltolarsen to treat Duchenne muscular dystrophy. The drug was developed based on research by U of A … READ MORE